维普期刊资源整合服务平台（V6.5）

109篇 您的检索式：作者名="Lassus A"

选中清除导出查看参考文献查看引证文献引用追踪共6页首页上一页第1页下一页末页 /6 跳转

	题名	作者	年代	出处	被引量
1	Ezrin immunoreacflvlty in relation to survival in serious ovarian patients显示文摘	Moilanen J Lassus H Leminen A et at	2003	Gynecol oneol2003，90，2：	1
2	Effects of dietary supp-lementationwith polyunsaturated ethyl ester lipids(Angiosan)inpatients with psoriasis and psoriatic arthritis显示文摘	Lassus A Dahlgren AL Halpern MJ	1990	J Int Med Res1990，18，1：	1
3	Gene amplification,mutation and protein expression of EGFR and mutations of ERBB2 in serous ovarian carcinoma显示文摘	Lassus H Sihto H Leminen A	2006	J Mol Med2006，84，8：	1
4	Ezrin immunoreactlvlty in relation to survival in serious ovarian patients显示文摘	Moilanen J Lassus H Leminen A	2003	Gynecol oneol2003，90，2：	1
5	Hyperglycemia and out- come in acute heart failure显示文摘	Mebazaa A Gayat E Lassus J	2013	JACC2013，61，8：	1
6	Ezrin immunoreaetivity in relationship to survival in serous ovarian carcinoma patients显示文摘	Moilanen J Lassus H Leminen A	2003	Gynecol Oncol2003，90，2：	1
7	ERBB2 amplification is superior to protein expression status in predicting patient outcome in serous ovarian carcinoma显示文摘	Lassus H Leminen A Vayrynen A	2004	Gynecol Oncol2004，92，1：	1
8	A comparative pilot study of azapropazone and indomethacin in the treatment of psoriatic arthritis and Reiter's disease 显示文摘	Lassus A	1976	Curr Med Res Opin1976，4，1：	1
9	Ezrin immunoreactivity in relation to survival in serous ovarian carcinoma patients显示文摘	LASSUS H LEMINEN A	2003	Gynecol Oncol2003，90，2：	1
10	A thermoelectric sensor for fluid flow measurement显示文摘	Stachowiak H Lassue A	1998	Flow Meas Instrum1998，9，3：	1
11	Gene amplification, mutation, and protein expression of EGFR and mutations of ERBB2 in serous o- varian carcinoma显示文摘	Lassus H Sihto H Leminen A	2006	J Mol Med2006，84，8：	1
12	Ezrin immunoreactivity in relation to survival in serous ovarian carcinoma patients显示文摘	MOILANEN J LASSUS H LEMINEN A	2003	Gynecol Oncol2003，90，2：	1
13	Ezrin immunore- activity in relation to survival in serous ovarian carcinoma patienls显示文摘	Moilanen J Lassus H Leminen A	2003	Gynecol Oncol2003，90，2：	1
14	Ezrin immunoreactivity in relation to survival in serous ovarian carcinoma patients 显示文摘	Moilanen J Lassus H Leminen A	2003	Gynecol Oncol2003，90，2：	1
15	Prognostic role of CIP2A expression in serous ovarian cancer显示文摘	Bockelman C Lassus H Hemmes A	2011	Br J Cancer2011，105，7：	1
16	Cytoplasmic HuR expression correlates with epithelial cancer cell but not with stromal cell cyclooxygenase-2 expression in mucinous ovarian carcinoma显示文摘	Sivula A Lassus H	2005	Gynecol Oncol2005，99，1：	1
17	Prognostic role of CIP2A expression in serous ovarian cancer显示文摘	Bockelman C Lassus H Hemmes A		0，，07：	1
18	Ezrin immu- noreactivity in relation to survival in serous ovarian car- cinoma patients 显示文摘	Moilanen J Lassus H Leminen A	2003	Gynecol Oncol2003，90，2：	1
19	Gene amplification, mutation, and protein expression of EGFR and mutations of ERBB2 in serous ovarian carcinoma 显示文摘	Lassus H Sihto H Leminen A	2006	J Mol Med2006，84，8：	1
20	Ezrin immunoreactivity in relation to survival in serous ovarian carcinoma patients显示文摘	Moilanen J Lassus H Leminen A	2003	Gynecol Oncol2003，90，2：	1

返回顶部每页显示：

共6页首页上一页第1页下一页末页 /6 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示